Literature DB >> 5459061

Relationship among contraction, drug binding and positive inotropic action of digoxin.

B F Roth-Schechter, G T Okita, D Anderson, F Richardson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5459061

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  7 in total

1.  Interdependence of ion transport and the action of quabain in heart muscle.

Authors:  M Bentfeld; H Lüllmann; T Peters; D Proppe
Journal:  Br J Pharmacol       Date:  1977-09       Impact factor: 8.739

2.  Reduction of the equilibrium binding of cardiac glycosides and related compounds to Na+,K+-ATPase as a possible mechanism for the potassium-induced reversal of their toxicity.

Authors:  T Akera; K Temma; S A Wiest; T M Brody
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-09       Impact factor: 3.000

3.  Ouabain: temporal relationship between the inotropic effect and the in vitro binding to, and dissociation from, (Na + + K + )- activated ATPase.

Authors:  T Akera; S I Baskin; T Tobin; T M Brody
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

4.  Extracellular versus intracellular digoxin action on bovine myocardium, using a digoxin antibody and intracellular glycoside application.

Authors:  P Hess; P Müller
Journal:  J Physiol       Date:  1982-01       Impact factor: 5.182

5.  The isolation of digoxin-specific antibody and its use in reversing the effects of digoxin.

Authors:  J Curd; T W Smith; J C Jaton; E Haber
Journal:  Proc Natl Acad Sci U S A       Date:  1971-10       Impact factor: 11.205

6.  [The problem of the cellular receptor for cardiac glycosides (author's transl)].

Authors:  H H Bodemann
Journal:  Klin Wochenschr       Date:  1981-12-15

7.  Digoxin concentration in right atrial myocardium, skeletal muscle and serum in man: influence of atrial rhythm.

Authors:  T Jogestrand
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.